Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > agents & regimens > BAM-002

BAM-002 : Novelos Therapeutics

BAM-002 in NSCLC (Novelos Therapeutics)
Describes the Phase II trial of BAM-002 for NSCLC that compares BAM-002 plus chemotherapy to chemotherapy alone. Notes encouraging results of a previous (controlled) trial conducted in Russia.


Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2006, Lung Cancer Online Foundation
Last modified: 18-Feb-2009
Karen Parles, MLS Editor